Bydureon
Also known as Bydureon — this name points to Exenatide in our directory.
Also known as Bydureon — this name points to Exenatide in our directory.
The first approved GLP-1 mimetic—derived from Gila monster saliva peptide exendin-4.
Exenatide was isolated from the Gila monster and modified for human use. It lowers blood glucose and modestly reduces weight. Largely replaced by newer GLP-1 drugs but remains a reference point for the peptide drug class.
Bydureon is a prescription drug brand—not a cosmetic INCI name or bulk research powder. The active molecule is Exenatide. Dosing, indications, and side effects come from the FDA label and your clinician, not peptide forum stacks.
Yes. Bydureon is a brand or nickname that refers to Exenatide in our directory—the same active molecule, different packaging or marketing name.
The first approved GLP-1 mimetic—derived from Gila monster saliva peptide exendin-4. Exenatide was isolated from the Gila monster and modified for human use. It lowers blood glucose and modestly reduces weight. Largely replaced by newer GLP-1 drugs but remains a reference point for the peptide drug class.
No. Bydureon is a prescription medicine dispensed through pharmacies with a clinician—not a peptide powder or cosmetic serum you buy by alias alone.